Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies()

BACKGROUND: Monthly intravenous immunoglobulin (IVIG) and weekly subcutaneous immunoglobulin (SCIG) have been regarded as therapeutically equivalent treatments for primary immunodeficiency diseases (PIDD). Immunoglobulin G (IgG) trough level is used as a monitoring measure for infection prevention....

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Pragya, Karmacharya, Paras, Wang, Zhen, Donato, Anthony, Joshi, Avni Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796775/
https://www.ncbi.nlm.nih.gov/pubmed/31641401
http://dx.doi.org/10.1016/j.waojou.2019.100068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796775/
https://www.ncbi.nlm.nih.gov/pubmed/31641401
http://dx.doi.org/10.1016/j.waojou.2019.100068

Ejemplares similares